N@N

MI, NCS, XIDE, CTIC. Abnormal Price Friction In Morning Trading Session Today

^{Published on 2009-06-30 07:46:20, Last Modified on 2010-12-22 14:19:46 - WOPRAI}
 

June 30, 2009 / M2 PRESSWIRE / BUYINS.NET, www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for June 30, 2009. Since late October market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This afair market makinga requirement is designed to prevent market makers from manipulating stock prices. Here is a list of the companies with Abnormal Price Friction (unfair market) in their stock prices in todaya�s trading session. This means that there was more buying than selling in the stocks and their stock prices dropped. Marshall and Ilsley (NYSE: MI), NCI Building Systems (NYSE: NCS), Exide Technologies (NASDAQ: XIDE) and Cell Therapeutics (NASDAQ: CTIC). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net .

Market Maker Friction Factor is shown in the chart below:

Symbol Change % BuyVol Buy% SellVol Sell% NetVol Friction

MI -$0.24 -4.83% 1,005,820 46.75% 906,758 42.15% 99,062 abnormal

NCS -$0.21 -7.29% 259,328 51.88% 192,065 38.43% 67,263 abnormal

XIDE -$0.13 -3.52% 119,595 50.26% 118,094 49.63% 1,501 abnormal

CTIC -$0.07 -4.04% 4,327,251 61.34% 2,726,957 38.66% 1,600,294 abnormal

Click here to view chart:

Analysis of the Friction Factor chart above shows that each of the stocks mentioned above had more buying than selling on Tuesday, June 30th, 2009 and their stock prices dropped. The Friction Factor displays how many more shares of buying than selling are required to move a stock higher by one cent or how many more shares of selling than buying moves a stock lower by 1 cent.

For example, the chart above shows MI with 99,062 greater shares of buying than selling (NetVol) and the stock price is down -$0.24. This means the Market Makers were trading the stock in a way inconsistent with normal supply and demand (Economics 101); more buying than selling should cause prices to rise.

Marshall & Ilsley Corporation (NYSE: MI) provides diversified financial services to corporate, institutional, government, and individual customers in the United States. Its Commercial Banking segment provides various corporate, commercial, and real estate banking products and services, including traditional commercial loans and lines of credit, letters of credit, asset-based lending, equipment financing, mezzanine financing, global trade services, treasury management, and other financial services to middle market, corporate, and public sector customers, as well as secured and unsecured lines of credit, construction loans, and land acquisition and development loans for commercial and residential development. The companya�s Community Banking segment offers consumer and business banking products and services, including mortgages, home equity loan and lines, credit cards, student loans, personal lines of credit and term loans, demand deposit accounts, interest bearing transaction accounts, and time deposits, as well as commercial real estate construction loans, agricultural loans, and secured and unsecured lines and term loans. Its Wealth Management segment provides asset management, trust, and banking services, as well as offers retirement plan services, taft-hartley services, not-for-profit services, north star deferred exchange, and trust operations outsourcing. The company also provides derivative solutions and investment services, currency conversion and foreign exchange services, and risk management to corporate, business banking, and financial institution clients. As of December 31, 2008, it operated 137 branch offices in Phoenix and Tucson, Arizona metropolitan areas, Kansas City and nearby communities, Floridaa�s west coast and Orlando, Florida, Minneapolis/St. Paul and Duluth, Minnesota, and central Indiana; and 17 offices in the St. Louis metropolitan area. The company was founded in 1847 and is headquartered in Milwaukee, Wisconsin.

NCI Building Systems, Inc. (NYSE: NCS) manufactures and markets metal products for the nonresidential construction industry in North America. The companya�s Metal Coil Coating segment consists of cleaning, treating, and painting various flat rolled metal coil substrates, as well as slitting and/or embossing the painted coils, before the steel is fabricated for use by various industrial users. It also cleans, treats, and coats hot-roll metal coils and light gauge metal for third parties for applications, such as construction products, heating and air conditioning systems, water heaters, lighting fixtures, ceiling grids, office furniture, and other products; and provides toll coating services and package coating. This segment serves other manufacturers of engineered building systems and metal components. Its Metal Components segment designs, manufactures, sells, and distributes metal components for construction applications, as well as for repair and retrofit uses. Its metal components include metal roof and wall systems, metal partitions, metal trim, doors, and other related accessories. This segment also manufactures roll-up doors; and sells interior and exterior walk doors for use in the self storage industry, and metal and other buildings. It sells metal components directly to regional manufacturers, contractors, subcontractors, distributors, lumberyards, cooperative buying groups, and other customers. The companya�s Engineered Building Systems segment designs, engineers, manufactures, and markets engineered building systems and self-storage building systems for commercial, industrial, agricultural, governmental, and community markets. This segment sells its products to builders, general contractors, developers, private labels, and end users through an in-house sales force. NCI Building Systems, Inc. was founded in 1984 and is headquartered in Houston, Texas.

Exide Technologies (NASDAQ: XIDE), together with its subsidiaries, engages in the manufacture and supply of lead acid batteries for transportation and industrial applications in the Americas, Europe, and internationally. The company operates in two segments, Transportation and Industrial Energy. The Transportation segment offers batteries, including ignition and lighting batteries for cars, trucks, off-road vehicles, agricultural and construction vehicles, motorcycles, recreational vehicles, marine, and other applications. It offers batteries for the transportation market under the Centra, DETA, Exide, Exide Extreme, Exide NASCAR Select, Orbital, Fulmen, and Tudor brands, as well as other private labels brands. The Industrial Energy segment offers batteries for motive power and network power applications, as well as offers a range of battery chargers and related equipment for the operation and maintenance of battery-powered vehicles. Its motive power batteries are used in the material handling industry for electric forklift trucks, as well as in other industries, including floor cleaning machinery, powered wheelchairs, railroad locomotives, mining, and the electric road vehicles market. This segmenta�s network power batteries are used to provide back-up power for use with telecommunications systems, computer installations, hospitals, air traffic control, security systems, utility, railway, and military applications. The company sells its aftermarket transportation products through various distribution channels, including mass merchandisers, auto parts outlets, wholesale distributors, and battery specialists; and original equipment manufacturers transportation replacement products principally through dealer networks. Exide Technologies was founded in 1888 and is based in Milton, Georgia.

Cell Therapeutics, Inc. (NASDAQ: CTIC), a biopharmaceutical company, develops, acquires, and commercializes oncology products for cancer treatment. Its development portfolio includes Pixantrone, a phase III trial product, for non-Hodgkina�s lymphoma; Brostallicin, which is in first-line Phase II study for the treatment of sarcoma; and OPAXIO, a chemotherapeutic agent for the potential treatment of non-small cell lung, ovarian, and other cancers. It has collaboration and licensing arrangements with Novartis International Pharmaceutical, Ltd.; and PG-TXL Company, L.P. The company was founded in 1991 and is headquartered in Seattle, Washington.

About BUYINS.NET

WWW.BUYINS.NET is a service designed to help bonafide shareholders of publicly traded US companies fight naked short selling. Naked short selling is the illegal act of short selling a stock when no affirmative determination has been made to locate shares of the stock to hypothecate in connection with the short sale. Buyins.net has built a proprietary database that uses Threshold list feeds from NASDAQ, AMEX and NYSE to generate detailed and useful information to combat the naked short selling problem. For the first time, actual trade by trade data is available to the public that shows the attempted size, actual size, price and average value of short sales in stocks that have been shorted and naked shorted. This information is valuable in determining the precise point at which short sellers go out-of-the-money and start losing on their short and naked short trades.

BUYINS.NET has built a massive database that collects, analyzes and publishes a proprietary SqueezeTrigger for each stock that has been shorted. The SqueezeTrigger database of nearly 2,600,000,000 short sale transactions goes back to January 1, 2005 and calculates the exact price at which the Total Short Interest is short in each stock. This data was never before available prior to January 1, 2005 because the Self Regulatory Organizations (primary exchanges) guarded it aggressively. After the SEC passed Regulation SHO, exchanges were forced to allow data processors like Buyins.net to access the data.

The SqueezeTrigger database collects individual short trade data on over 7,000 NYSE, AMEX and NASDAQ stocks and general short trade data on nearly 8,000 OTCBB and PINKSHEET stocks. Each month the database grows by approximately 50,000,000 short sale transactions and provides investors with the knowledge necessary to time when to buy and sell stocks with outstanding short positions. By tracking the size and price of each montha�s short transactions, BUYINS.NET provides institutions, traders, analysts, journalists and individual investors the exact price point where short sellers start losing money and a short squeeze can begin.

All material herein was prepared by BUYINS.NET, based upon information believed to be reliable. The information contained herein is not guaranteed by BUYINS.NET to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion. None of the companies in this report have paid to be included in this report. From time to time we will mention a company that may have previously paid $995 per month for market data purchased from BUYINS.NET. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. BUYINS.NET is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. BUYINS.NET will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.

BUYINS.NET, FRICTION FACTOR and SQUEEZETRIGGER are intended for use by stock market professionals. As a member, visitor, or user of any kind, you accept full responsibilities for your investment and trading actions. The contents of BUYINS.NET, including but not limited to all implied or expressed views, opinions, teachings, data, graphs, opinions, or otherwise are not predictions, warranty, or endorsements of any kind. Please seek stock market advice from the proper securities professional, or investment advisor.

By visiting BUYINS.NET or using any data or services, you agree to assume full responsibility for the decisions or actions that you undertake. BUYINS.NET, LLC, its owner(s), operators, employees, partners, affiliates, advertisers, information providers and any other associated person or entity, shall under no circumstances be held liable to the user and/or any third party for loss or damages of any kind, including but not limited to trading losses, lost trading opportunity, direct, indirect, consequential, special, incidental, or punitive damages. As a user, you agree that any damages collected shall not exceed the amount paid to BUYINS.NET and/or its owners. As a website user, you agree that any and all legal matters of any kind are to be reviewed and handled in their entirety within the State of California only. By using the services of this website, you are consenting to the terms as outlined, and forfeit all legal jurisdictions in any other State. Past performance is not a guarantee of future outcomes. Any and all examples are hypothetical and should not be considered a guarantee or endorsement of such trading activity. BUYINS.NET does not take responsibility for problems of any kind, including but not limited to issues with operations, data accuracy or completeness, contacting issues, technical issues, and timeliness. BUYINS.NET places great integrity on the data collected and distributed. This information is deemed reliable, but not guaranteed. All information and data is provided "as is" without warranty or guarantee of any kind.

Please seek investment and/or trading advice, council, information or services from a securities professional. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and BUYINS.NET undertakes no obligation to update such statements.

This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the SEC.

Contact: Thomas Ronk, CEO www.BUYINS.net +1-800-715-9999 Tom@buyins.net